Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ATRC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 -3.598M
March 31, 2026 11.28M
December 31, 2025 -2.419M
September 30, 2025 -0.035M
June 30, 2025 -3.711M
March 31, 2025 10.04M
December 31, 2024 -2.019M
September 30, 2024 -0.003M
June 30, 2024 -3.26M
March 31, 2024 6.147M
December 31, 2023 -2.62M
September 30, 2023 -0.38M
June 30, 2023 -3.237M
March 31, 2023 5.217M
December 31, 2022 -2.219M
September 30, 2022 0.18M
June 30, 2022 -2.081M
March 31, 2022 10.28M
December 31, 2021 -2.225M
September 30, 2021 0.39M
June 30, 2021 -3.019M
March 31, 2021 10.51M
December 31, 2020 -6.653M
September 30, 2020 0.083M
June 30, 2020 -191.26M
Date Value
March 31, 2020 7.74M
December 31, 2019 -1.524M
September 30, 2019 0.022M
June 30, 2019 -1.85M
March 31, 2019 8.521M
December 31, 2018 -84.28M
September 30, 2018 -0.834M
June 30, 2018 -3.579M
March 31, 2018 1.878M
December 31, 2017 -1.115M
September 30, 2017 -1.006M
June 30, 2017 -3.482M
March 31, 2017 1.104M
December 31, 2016 -0.75M
September 30, 2016 -0.249M
June 30, 2016 -1.358M
March 31, 2016 -0.897M
December 31, 2015 -0.717M
September 30, 2015 -0.489M
June 30, 2015 -2.175M
March 31, 2015 -0.013M
December 31, 2014 -0.738M
September 30, 2014 0.025M
June 30, 2014 -0.843M
March 31, 2014 -67.18M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp. 1.995B
Abbott Laboratories 1.042B
AngioDynamics, Inc. 0.011M
Alphatec Holdings, Inc. -2.166M
Baxter International, Inc. -5.00M